Here's Why Vanda Pharmaceuticals Jumped Higher Today

Shares of Vanda Pharmaceurticals (NASDAQ:VNDA) are up 8.7% at 2:35 p.m. EST after the drugmaker gained an expanded Food and Drug Administration (FDA) approval for its sleep drug Hetlioz. The new approval covers patients with Smith-Magenis syndrome (SMS), a rare neurodevelopmental disorder.